undamentalytics Newsletter
Sign in

Synopsys Inc (SNPS) stock

Add to watchlist

Add holding +

NASDAQ: SNPS Nasdaq Application Software Next results ~December 9, 2026

B Fundamentals grade

Synopsys supplies the software and hardware engineers use to design and test integrated circuits, the chips in electronic devices. Its electronic design automation (EDA) tools — among them Fusion Compiler, PrimeTime, VCS, Verdi and ZeBu emulation systems — automate the design and verification of complex chips, increasingly aided by its Synopsys.ai suite. After acquiring Ansys, it also sells simulation and analysis software such as Ansys Fluent and Ansys Mechanical, which predict how physical products behave. A third line is pre-designed semiconductor intellectual property (IP) — logic libraries, memory and interface blocks, security IP and ARC processors — that customers build into their chips.

EDA and IP customers are mainly semiconductor and electronics companies, while the simulation software serves industries from aerospace and defence to automotive, energy, healthcare and construction, and academia. It earns money by licensing software and IP, selling hardware systems, and providing support, training and consulting; it also offers a cloud option with Microsoft Azure.

It operates through two segments, Design Automation and Design IP, selling via direct teams and independent channel partners. Based in Sunnyvale, California, Synopsys runs 189 offices worldwide, with sites across Europe, Israel, Asia and the Americas.

Based on Synopsys Inc's 10-K filed December 22, 2025.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: after-tax interest is 53% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

Price vs value

Under review: after-tax interest is 53% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy. We'll show the comparison once resolved.

Synopsys Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Synopsys files

Where Synopsys stands after its latest 10-Q

Revenue for the twelve months to July 2026 was $9.42bn, up 46.3% on a year earlier, faster than 39.5% a quarter earlier. That growth ranks 2 of 27 among the application software companies we cover. Free-cash-flow margin rose to 29.2% from 20.0% a year earlier. Operating margin narrowed to 8.5% from 17.2%. The diluted share count is up 21.2% on a year earlier, which dilutes existing holders. Against its peers on growth, profitability, cash generation and balance sheet, it grades C+. It passes 3 of our 7 financial-health checks. At that price, our model says the market is pricing in about 31.3% a year of cash-flow growth for five years, faster than the 17.5% a year revenue growth it has delivered.

Our model value for Synopsys is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 26, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~December 9, 2026 (estimated)

Synopsys Inc's trailing-twelve-month revenue grew 46.3% year on year, with a free-cash-flow margin of 29.2%. Where it stands out: revenue growth of 46.3% ranks 17 of 184 application software companies we cover. Where it lags: change in share count of 21.2% ranks 138 of 163 application software companies we cover.

Our discounted-cash-flow model values the business at ~$200 per share in the base case (~$140–$270 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow grew 113.7% while net income fell 46.1%: a 160pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 46.3% over the last 12 months, against a median of 12.0% for application software companies we cover.
  • Growth speeding up. The growth rate is 6.8 points higher than a quarter earlier.
  • Strong cash generation. 29.2% of revenue turned into free cash flow, against a median of 15.2% for application software companies we cover.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 7.5% over 90 days.

Things to watch

  • Margins narrowing. Operating margin is down 8.6 points on a year ago.
  • Share dilution. Diluted shares rose 21.2% in a year.
  • High earnings multiple. The shares trade at 83 times the last 12 months' earnings, so expectations are demanding.
  • Volatile shares. Over the past year the shares showed annualised volatility of 45% and a beta of 1.7 against the S&P 500.
  • Insiders selling. 5 insiders sold $62M of stock over the past 365 days and none bought (89% under pre-set trading plans).
  • Gross margin slipping. Gross margin is down 6.7 points on a year ago.

Latest results: FY2026 Q3

Filed August 26, 2026
Earnings per share
$3.91 against an average estimate of $3.67: beat by 6.4%
Revenue
$2.48bn, up 42.4% on a year earlier
Share reaction
+13.7% in the first session after the results on August 26, 2026, against +0.7% for the S&P 500
Guidance given
revenue $2,530m to $2,580m (Range for Three Months Ending October 31, 2026); revenue $9,690m to $9,740m (Range for Fiscal Year Ending October 31, 2026)
Next report
December 9, 2026; average EPS estimate $4.13

Synopsys' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-0.3%
  • 1 week+2.6%
  • 1 month-4.9%
  • This year-0.8%
  • 1 year+2.7%
  • 5 years+39.8%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$9.4B
Operating margin
8.5%
Net margin
11.4%
EPS (TTM, diluted)
$5.64

Growth

Revenue growth
+46.3%
Change in growth rate
+6.8 pts
Share count change
+21.2%

Cash

Free cash flow (TTM)
$2.7B
FCF margin
29.2%
Stock pay % of revenue
10.1%

Earnings

Last results
August 26, 2026
Next results (est.)
November 25, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Insider trade
  2. Insider trade
  3. Buyback
  4. Announcement
  5. Insider trade
  6. Announcement
  7. Announcement
  8. Announcement
  9. Announcement
  10. Partnership
  11. Insider trade
  12. Insider trade
  13. Insider trade
  14. Insider trade
  15. Results
  16. Guidance
  17. Leadership
  18. Announcement
  19. Announcement
  20. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Synopsys Inc valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: after-tax interest is 53% of the cash flow left for shareholders; our flat discount rate doesn't yet reflect debt this heavy.

The inputs used by the models below have passed source checks. Individual model values are available below and in the interactive valuator. Their differences are shown explicitly; the platform combined value and recommendation remain withheld.

Valuation models

We value Synopsys Inc as an operating company, with every model that fits that kind of business. Cost of equity 10.9%: the 10-year Treasury yield (4.9%) plus a beta of 1.32 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. — Does not apply: This model is withheld pending its input or assumption review.
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. — Does not apply: This model is withheld pending its input or assumption review.
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$260 ~$210–$430 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$260 ~$180–$370 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$240 ~$220–$280 Included
Combined value Individual source-checked model scenarios are available. The platform combined value and recommendation remain withheld. — Combined value withheld. Review the individual models and their assumptions.

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Synopsys Inc with Application Software in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$49.98$59.31$86.52$89.53$135.75$213.86$333.18$292.55$469.44$513.61$453.82$466.08
Market value$7.9bn$9.2bn$13.4bn$13.7bn$20.9bn$33.3bn$52.4bn$45.8bn$72.9bn$80.1bn$75.2bn$89.0bn
+ Net debt (− = net cash)−$631m−$772m−$904m−$254m−$591m−$1.1bn−$1.3bn−$1.4bn−$1.4bn−$3.9bn$10.7bn$6.5bn
Enterprise value$7.3bn$8.4bn$12.5bn$13.5bn$20.3bn$32.2bn$51.1bn$44.4bn$71.4bn$76.2bn$85.9bn$95.5bn
Multiples
Price / sales 3.5x3.8x4.9x4.4x6.2x9.0x12.5x9.0x13.7x13.1x10.7x9.5x
Price / earnings 35.0x34.4x98.1x31.8x39.3x50.1x69.2x46.5x59.2x35.4x56.4x82.7x
Price / free cash flow 19.4x17.7x23.8x42.2x34.7x39.8x37.5x28.6x48.1x63.2x55.7x32.4x
EV / EBITDA 15.2x16.0x23.3x23.7x28.2x38.8x54.4x32.2x47.0x46.2x54.5x36.5x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

59 /100

Moderate moat

How hard Synopsys's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 26.0% of total assets over 10 years.

  • Pricing power 20 / 20

    Gross margin has been a median 77.8%, moving by 2.5 percentage points (standard deviation) across 10 years.

  • Durability 12 / 20

    Operating margin has been a median 16.5%; its worst year was 8.5%.

  • Cash conversion 20 / 20

    Free cash flow was positive in 10 of 10 years, at a median 21.6% of revenue.

  • Discipline 2 / 20

    The diluted share count rose 21.4% over five years; stock-based pay has been a median 8.4% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (74 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: December 9, 2026, after the close. Analysts expect revenue of $2.6bn and EPS of $4.13 (range $4.01 to $4.25) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $15.14 +17% $9.7bn +38%
Next $18.58 +23% $11.0bn +13%

Next year's EPS estimate has moved +7.5% in 90 days, across 20 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +2.5% on 90 days ago. In the last 30 days, 0 analysts raised Synopsys Inc's forecast and 1 cut it.

Consensus EPS forecast Synopsys Inc, last 90 days
$14.00 $15.00 $16.00 $17.00 $18.00 $19.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $14.77 Current fiscal year, 60 days ago: $15.11 Current fiscal year, 30 days ago: $15.14 Current fiscal year, 7 days ago: $15.14 Current fiscal year, Now: $15.14 $15.14 Next fiscal year, 90 days ago: $17.28 Next fiscal year, 60 days ago: $17.51 Next fiscal year, 30 days ago: $17.69 Next fiscal year, 7 days ago: $18.73 Next fiscal year, Now: $18.58 $18.58

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $14.77$17.28
60 days ago $15.11$17.51
30 days ago $15.14$17.69
7 days ago $15.14$18.73
Now $15.14$18.58

Earnings against estimates

Quarter toEstimateActualSurprise
Jul 2026 $3.67 $3.91 +6.4%
Apr 2026 $3.16 $3.35 +5.9%
Jan 2026 $3.56 $3.77 +6.0%
Oct 2025 $2.78 $2.90 +4.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 26, 2026
  • Revenue Range for Fiscal Year Ending October 31, 2026 $9,690m to $9,740m
    “Revenue (1) $ 2,530 $ 2,580 $ 9,690 $ 9,740” source
  • total revenue full-year about $9.715bn Raised
    “Raising expectations for full-year total revenue to $9.715 billion at the midpoint and full-year non-GAAP EPS guidance to $15.07 at the midpoint on continued AI-driven demand strength” source
  • Revenue Range for Three Months Ending October 31, 2026 $2,530m to $2,580m
    “Revenue (1) $ 2,530 $ 2,580 $ 9,690 $ 9,740” source
  • GAAP EPS Range for Fiscal Year Ending October 31, 2026 $3.84 to $4.08 GAAP
    “GAAP EPS $ 0.60 $ 0.85 $ 3.84 $ 4.08” source
  • Non-GAAP EPS Range for Fiscal Year Ending October 31, 2026 $15.04 to $15.10 Non-GAAP
    “Non-GAAP EPS $ 4.10 $ 4.16 $ 15.04 $ 15.10” source
  • non-GAAP EPS full-year about $15.07 Non-GAAP Raised
    “Raising expectations for full-year total revenue to $9.715 billion at the midpoint and full-year non-GAAP EPS guidance to $15.07 at the midpoint on continued AI-driven demand strength” source
Show 13 more items
  • GAAP EPS Range for Three Months Ending October 31, 2026 $0.60 to $0.85 GAAP
    “GAAP EPS $ 0.60 $ 0.85 $ 3.84 $ 4.08” source
  • Non-GAAP EPS Range for Three Months Ending October 31, 2026 $4.10 to $4.16 Non-GAAP
    “Non-GAAP EPS $ 4.10 $ 4.16 $ 15.04 $ 15.10” source
  • GAAP Operating Margin Range for Fiscal Year Ending October 31, 2026 about 10.4% GAAP
    “GAAP Operating Margin Midpt: ~10.4%” source
  • Non-GAAP Operating Margin Range for Fiscal Year Ending October 31, 2026 about 41.5% Non-GAAP
    “Non-GAAP Operating Margin Midpt: ~41.5%” source
  • GAAP Expenses Range for Fiscal Year Ending October 31, 2026 $8,667m to $8,742m GAAP
    “GAAP Expenses $ 2,225 $ 2,300 $ 8,667 $ 8,742” source
  • Non-GAAP Expenses Range for Fiscal Year Ending October 31, 2026 $5,670m to $5,700m Non-GAAP
    “Non-GAAP Expenses $ 1,450 $ 1,480 $ 5,670 $ 5,700” source
  • Non-GAAP Tax Rate Range for Fiscal Year Ending October 31, 2026 about 18% Non-GAAP
    “Non-GAAP Tax Rate 18 % 18 % 18 % 18 %” source
  • Operating Cash Flow Range for Fiscal Year Ending October 31, 2026 about $2,800m
    “Operating Cash Flow ~$2,800” source
  • Free Cash Flow Range for Fiscal Year Ending October 31, 2026 about $2,600m
    “Free Cash Flow (2) ~$2,600” source
  • Capital Expenditures Range for Fiscal Year Ending October 31, 2026 about $225m
    “Capital Expenditures ~$225” source
  • GAAP Expenses Range for Three Months Ending October 31, 2026 $2,225m to $2,300m GAAP
    “GAAP Expenses $ 2,225 $ 2,300 $ 8,667 $ 8,742” source
  • Non-GAAP Expenses Range for Three Months Ending October 31, 2026 $1,450m to $1,480m Non-GAAP
    “Non-GAAP Expenses $ 1,450 $ 1,480 $ 5,670 $ 5,700” source
  • Non-GAAP Tax Rate Range for Three Months Ending October 31, 2026 about 18% Non-GAAP
    “Non-GAAP Tax Rate 18 % 18 % 18 % 18 %” source

How earlier guidance turned out

  • GAAP EPS, Range for Three Months Ending July 31, 2026 guided $0.84 to $0.98 Above range: $2.84
  • Revenue, Range for Three Months Ending July 31, 2026 guided $2,410m to $2,460m Above range: $2,477m

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

25 analysts, Nov 2026
Buy2392%
Hold28%
Sell00%

Monthly trend

  1. Nov 2026320225
  2. Oct 2026419225
  3. Sep 2026316525

Counts of recommendations published by analysts covering Synopsys Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
3.4%
of tradable shares
Days to cover
2.51
at average volume
Short interest, 1 month
+13%
to October 15, 2026
Held by institutions
93%
of shares
Held by insiders
3.0%
of shares
Employees
28,000
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

What moved the share price

Last 12 months +2.7%

$453.82 on October 31, 2025 to $466.08

ThenNowEffect
Revenue (last 12 months) $6.4bn $9.4bn +46.3%
Net margin 31.0% 11.4% −63.2%
P/E multiple 35.8x 82.7x +130.9%
Share count 158m 191m −17.5%

Biggest factor: net margin.

Last 3 years −4.5%

$487.94 on November 3, 2023 to $466.08

ThenNowEffect
Revenue (last 12 months) $5.3bn $9.4bn +78.9%
Net margin 19.7% 11.4% −41.8%
P/E multiple 73.3x 82.7x +12.8%
Share count 155m 191m −18.6%

Biggest factor: revenue.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
SNPS+42%−13%+61%−6%−3%−1%
Industry peers (median)−8%−50%+19%+2%−21%−14%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
SNPS67%42%75%50%50%27%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
SNPS−25%−29%−10%−25%−41%−31%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since October 29, 2015: 43% from July 30, 2025 to September 15, 2026. Getting back needed a 76% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$367.70 – $534.56
From 52-week high
−12.8%
vs 50-day average
+6.2%
vs 200-day average
+5.1%
Volatility (1 year)
45%
Beta vs S&P 500
1.67

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
4 up, 8 down
typical move ±8.1%
After a week
2 up, 10 down
typical move ±6.7%
After a month
4 up, 8 down
typical move ±8.9%
Results releasedNext dayS&P 500 next day5 days21 days
August 26, 2026 +13.7% +0.7% +1.8% +4.2%
May 27, 2026 −10.1% +0.5% −6.8% −15.0%
February 25, 2026 −3.3% +0.3% −2.2% −8.8%
December 10, 2025 +2.4% +0.9% −2.7% +14.5%
September 9, 2025 −36.3% +0.5% −30.1% −19.7%
May 28, 2025 −11.1% −0.2% −7.5% −1.8%
February 26, 2025 −0.7% −1.5% −2.2% −2.6%
December 4, 2024 −9.6% +0.5% −10.2% −12.1%
August 21, 2024 −1.6% −0.4% −8.4% −9.0%
May 22, 2024 +2.6% −1.0% −1.2% +4.2%
February 21, 2024 +6.0% +2.2% +4.1% +9.9%
November 29, 2023 −0.1% +0.3% −3.0% −5.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Synopsys Inc in five measures

Fundamentals grade B
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Synopsys Inc
$5B $6B $7B $8B $9B $10B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $5.4B Revenue (TTM), FY24 Q1: $5.6B Revenue (TTM), FY24 Q2: $5.8B Revenue (TTM), FY24 Q3: $6B Revenue (TTM), FY24 Q4: $6.1B Revenue (TTM), FY25 Q1: $6.1B Revenue (TTM), FY25 Q2: $6.2B Revenue (TTM), FY25 Q3: $6.4B Revenue (TTM), FY25 Q4: $7.1B Revenue (TTM), FY26 Q1: $8B Revenue (TTM), FY26 Q2: $8.7B Revenue (TTM), FY26 Q3: $9.4B $9.4B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $5.4B
FY24 Q1 $5.6B
FY24 Q2 $5.8B
FY24 Q3 $6B
FY24 Q4 $6.1B
FY25 Q1 $6.1B
FY25 Q2 $6.2B
FY25 Q3 $6.4B
FY25 Q4 $7.1B
FY26 Q1 $8B
FY26 Q2 $8.7B
FY26 Q3 $9.4B
Revenue growth, TTM YoY Synopsys Inc
0% 20% 40% 60% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 7.2% Revenue growth, TTM YoY, FY24 Q1: 8.2% Revenue growth, TTM YoY, FY24 Q2: 12.2% Revenue growth, TTM YoY, FY24 Q3: 13.2% Revenue growth, TTM YoY, FY24 Q4: 12.5% Revenue growth, TTM YoY, FY25 Q1: 8.5% Revenue growth, TTM YoY, FY25 Q2: 7.5% Revenue growth, TTM YoY, FY25 Q3: 8.0% Revenue growth, TTM YoY, FY25 Q4: 15.1% Revenue growth, TTM YoY, FY26 Q1: 31.9% Revenue growth, TTM YoY, FY26 Q2: 39.5% Revenue growth, TTM YoY, FY26 Q3: 46.3% 46.3%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 7.2%
FY24 Q1 8.2%
FY24 Q2 12.2%
FY24 Q3 13.2%
FY24 Q4 12.5%
FY25 Q1 8.5%
FY25 Q2 7.5%
FY25 Q3 8.0%
FY25 Q4 15.1%
FY26 Q1 31.9%
FY26 Q2 39.5%
FY26 Q3 46.3%
Operating margin (TTM) Synopsys Inc
0% 10% 20% 30% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 23.4% Operating margin (TTM), FY24 Q1: 24.5% Operating margin (TTM), FY24 Q2: 24.3% Operating margin (TTM), FY24 Q3: 24.7% Operating margin (TTM), FY24 Q4: 22.1% Operating margin (TTM), FY25 Q1: 20.7% Operating margin (TTM), FY25 Q2: 20.9% Operating margin (TTM), FY25 Q3: 17.2% Operating margin (TTM), FY25 Q4: 13.0% Operating margin (TTM), FY26 Q1: 10.8% Operating margin (TTM), FY26 Q2: 7.0% Operating margin (TTM), FY26 Q3: 8.5% 8.5%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 23.4%
FY24 Q1 24.5%
FY24 Q2 24.3%
FY24 Q3 24.7%
FY24 Q4 22.1%
FY25 Q1 20.7%
FY25 Q2 20.9%
FY25 Q3 17.2%
FY25 Q4 13.0%
FY26 Q1 10.8%
FY26 Q2 7.0%
FY26 Q3 8.5%
FCF margin (TTM) Synopsys Inc
15% 20% 25% 30% 35% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 27.8% FCF margin (TTM), FY24 Q1: 23.5% FCF margin (TTM), FY24 Q2: 19.0% FCF margin (TTM), FY24 Q3: 16.8% FCF margin (TTM), FY24 Q4: 20.7% FCF margin (TTM), FY25 Q1: 21.2% FCF margin (TTM), FY25 Q2: 17.2% FCF margin (TTM), FY25 Q3: 20.0% FCF margin (TTM), FY25 Q4: 19.1% FCF margin (TTM), FY26 Q1: 28.5% FCF margin (TTM), FY26 Q2: 30.3% FCF margin (TTM), FY26 Q3: 29.2% 29.2%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 27.8%
FY24 Q1 23.5%
FY24 Q2 19.0%
FY24 Q3 16.8%
FY24 Q4 20.7%
FY25 Q1 21.2%
FY25 Q2 17.2%
FY25 Q3 20.0%
FY25 Q4 19.1%
FY26 Q1 28.5%
FY26 Q2 30.3%
FY26 Q3 29.2%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q, 10-Q/A. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Synopsys took in during FY2025, followed through to profit: what it cost to make, what went on research and running the business, and what was left after tax.

  1. Revenue $7.1B
  2. Other income $473M · 6.7%
  3. Cost of revenue $1.6B · 23.0%
  4. Gross profit $5.4B · 77.0%
  5. Research and development $2.5B · 35.1%
  6. Selling, general and admin $1.8B · 26.1%
  7. Other operating costs $193M · 2.7%
  8. Operating income $915M · 13.0%
  9. Income tax $56M · 0.8%
  10. Net income $1.3B · 18.9%

Shares of revenue. Source: Synopsys's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained. Other income is income outside operations, such as investment gains.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Oct 2009 2010 Oct 2010 2011 Oct 2011 2012 Oct 2012 2013 Oct 2013 2014 Oct 2014 2015 Oct 2015 2016 Oct 2016 2017 Oct 2017 2018 Oct 2018 2019 Oct 2019 2020 Oct 2020 2021 Oct 2021 2022 Oct 2022 2023 Oct 2023 2024 Oct 2024 2025 Oct 2025 LTM Jul 2026
Income
Revenue 1.4 1.4 1.5 1.8 2.0 2.1 2.2 2.4 2.7 3.1 3.4 3.7 4.2 5.1 5.3 6.1 7.1 9.4
Gross profit 1.1 1.1 1.2 1.4 1.5 1.6 1.7 1.9 2.1 2.4 2.6 2.9 3.3 3.7 4.3 4.9 5.4 6.8
EBITDA 0.3 0.3 0.3 0.3 0.4 0.4 0.5 0.5 0.5 0.6 0.7 0.8 0.9 1.4 1.5 1.7 1.6 2.6
Operating income 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.3 0.4 0.5 0.6 0.7 1.1 1.3 1.4 0.9 0.8
Net income 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.1 0.4 0.5 0.7 0.8 1.0 1.2 2.3 1.3 1.1
Diluted EPS $1.15 $1.56 $1.47 $1.21 $1.58 $1.64 $1.43 $1.73 $0.88 $2.82 $3.45 $4.27 $4.81 $6.29 $7.92 $14.51 $8.04 $5.64
Growth (year on year)
Revenue +1.7% +1.5% +11.2% +14.4% +11.7% +4.9% +9.0% +8.0% +12.5% +14.5% +7.7% +9.7% +14.1% +20.9% +4.7% +15.2% +15.1% +46.3%
EBITDA −2.1% −7.9% +19.7% +1.6% +25.1% +1.8% +8.3% +9.6% +2.4% +6.0% +26.8% +15.0% +13.1% +46.7% +10.4% +8.6% −4.6% +82.7%
Operating income −5.0% −11.6% +15.6% −10.7% +29.7% +0.9% +7.1% +19.1% +9.5% +3.6% +44.4% +19.2% +18.5% +56.3% +10.8% +6.5% −32.5% −27.3%
Net income −11.7% +41.4% −6.6% −17.8% +36.2% +4.6% −12.8% +18.1% −48.8% +216.7% +23.1% +24.8% +14.0% +30.0% +24.9% +84.0% −41.1% −46.1%
Diluted EPS −10.9% +35.7% −5.8% −17.7% +30.6% +3.8% −12.8% +21.0% −49.1% +220.5% +22.3% +23.8% +12.6% +30.8% +25.9% +83.2% −44.6% −55.5%
Margins
Gross margin 79.9% 79.6% 77.8% 77.6% 76.9% 77.8% 76.9% 77.6% 76.0% 76.4% 77.6% 78.4% 79.5% 73.2% 80.6% 79.7% 77.0% 72.4%
EBITDA margin 22.8% 20.7% 22.2% 19.8% 22.1% 21.5% 21.3% 21.6% 19.7% 18.2% 21.5% 22.5% 22.3% 27.1% 28.6% 26.9% 22.3% 27.8%
Operating margin 15.3% 13.3% 13.9% 10.8% 12.6% 12.1% 11.9% 13.1% 12.8% 11.5% 15.5% 16.8% 17.5% 22.6% 23.9% 22.1% 13.0% 8.5%
Net margin 12.3% 17.2% 14.4% 10.4% 12.6% 12.6% 10.1% 11.0% 5.0% 13.9% 15.8% 18.0% 18.0% 19.4% 23.1% 36.9% 18.9% 11.4%
Free-cash-flow margin 14.7% 21.9% 24.9% 24.6% 22.0% 21.8% 18.2% 21.5% 20.6% 10.4% 17.9% 22.7% 33.3% 31.5% 28.5% 20.7% 19.1% 29.2%
Cash flow
Cash from operations 0.2 0.3 0.4 0.5 0.5 0.6 0.5 0.6 0.6 0.4 0.8 1.0 1.5 1.7 1.7 1.4 1.5 2.9
Capital spending 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.2
Free cash flow 0.2 0.3 0.4 0.4 0.4 0.4 0.4 0.5 0.6 0.3 0.6 0.8 1.4 1.6 1.5 1.3 1.3 2.7
Stock-based pay 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.3 0.5 0.6 0.7 0.9 1.0
Free cash flow after stock pay 0.1 0.2 0.3 0.4 0.4 0.4 0.3 0.4 0.5 0.2 0.4 0.6 1.1 1.1 1.0 0.6 0.5 1.8
Balance sheet
Cash 0.7 0.8 0.9 0.7 1.0 1.0 0.8 1.0 1.0 0.7 0.7 1.2 1.4 1.4 1.4 3.9 2.9 3.6
Total debt 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.1 0.5 0.1 0.1 0.1 0.0 0.0 0.0 13.6 10.1
Net debt (negative = net cash) −0.7 −0.8 −0.9 −0.6 −0.9 −0.9 −0.6 −0.8 −0.9 −0.3 −0.6 −1.1 −1.3 −1.4 −1.4 −3.9 10.7 6.5
Diluted shares 146m 152m 150m 150m 157m 158m 158m 155m 155m 153m 154m 156m 157m 156m 155m 156m 166m 191m
Returned to shareholders
Buybacks — 0.2 0.4 0.0 0.1 0.1 0.3 0.4 0.4 0.4 0.3 0.2 0.8 1.1 1.2 0.0 0.0 —
Total returned — 0.2 0.4 0.0 0.1 0.1 0.3 0.4 0.4 0.4 0.3 0.2 0.8 1.1 1.2 0.0 0.0 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 7 checks passed · July 31, 2026
What it owns · $47.7bn
Short-term assets $6.6bnLonger-term assets $41.1bn
What it owes, and who funded it · $47.7bn
Short-term liabilities $5.0bnLonger-term liabilities $11.6bnShareholders' equity $31.2bn
  • Short-term assets cover short-term liabilities $6.6bn of assets due within a year against $5.0bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities $6.6bn short-term assets against $11.6bn of longer-dated liabilities.
  • More cash than debt $3.6bn of cash against $10.0bn of debt.
  • Debt below 40% of shareholders' equity Debt is 32% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 0% to 32% over five years.
  • A year's operating cash flow covers at least 20% of debt $2.9bn of operating cash flow against $10.0bn of debt.
  • Operating profit covers interest at least five times over Operating income of $802m against $624m of interest.

From Synopsys Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Buybacks, last 3 fiscal years
$1.2B
Diluted share count
+21.2%
year over year
R&D spending
30.6%
of revenue
Days sales outstanding
51 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in application software
Last 12 months unless stated SNPS WDAY ADSK PLTR TOST TEAM Median
Revenue, last 12 months $9.4bn $10.2bn $7.8bn $7.3bn $6.8bn $6.6bn $482m
Revenue growth, last 12 months 46.3% 13.3% 17.9% 87.1% 23.0% 26.0% 12.0%
Revenue growth, 3-year average 21.4% 14.8% 14.3% 50.8% 27.1% 23.0% 11.1%
Revenue growth, latest quarter 42.4% 12.8% 16.1% 95.9% 23.1% 27.6% 11.9%
Gross margin 72.4% 61.1% 91.2% 84.7% 26.7% 84.8% 69.2%
Operating margin 8.5% 10.7% 26.2% 45.6% 6.3% 0.2% 1.1%
Operating margin, 3-year average 16.8% 7.0% 23.2% 27.1% 2.0% −1.7% −0.8%
Net margin 11.4% 12.3% 21.1% 50.3% 7.1% −0.8% 2.1%
Cash from operations / revenue 31.2% 30.3% 37.2% 56.2% 9.3% 20.6% 18.2%
Free-cash-flow margin 29.2% 28.0% 36.4% 55.6% 8.5% 20.1% 15.0%
Free-cash-flow margin, 3-year average 22.0% 27.3% 28.1% 46.2% 7.2% 26.6% 16.2%
Stock pay / revenue 10.1% 16.2% 9.1% 13.5% 3.4% 24.4% 9.3%
Change in share count 21.2% −4.3% −1.5% 0.7% −1.1% −0.6% 2.2%

Median of all 185 companies we cover in application software. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

185 application software companies
Measure Company Peer median Rank
Revenue growth Growth 46.3% 12.0% 17 of 184
Change in growth rate Growth +6.8pp +0.2pp 29 of 184
Gross margin Profitability 72.4% 69.8% 72 of 160
Operating margin Profitability 8.5% 1.1% 65 of 181
Net margin Profitability 11.4% 2.1% 56 of 185
Free-cash-flow margin Cash generation 29.2% 15.2% 30 of 180
Stock pay as % of revenue Cash generation 10.1% 9.3% 97 of 177
Long-term debt as % of assets Balance sheet 18.9% 16.9% 58 of 98
Change in share count Balance sheet 21.2% 1.7% 138 of 163
Days sales outstanding Balance sheet 51 days 57 days 67 of 162

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to October 31, 2025
Segments
Line of business Revenue Share YoY
Design Automation $5.3B 75.2% ▲ 25.6%
Design IP $1.8B 24.8% ▼ 8.1%
Products and services
Line of business Revenue Share YoY
Products $5.5B 78.0% ▲ 9.4%
License and Maintenance $3.5B 63.4% ▲ 8.2%
Licenses $2B 36.6% ▲ 11.6%
Technology services $1.6B 22.0% ▲ 41.2%
Geography
Region Revenue Share YoY
United States $3.1B 43.9% ▲ 13.2%
Other Countries $1.3B 18.5% ▲ 29.1%
South Korea $947M 13.4% ▲ 22.5%
Europe $889M 12.6% ▲ 44.6%
China $814M 11.5% ▼ 17.7%

From Synopsys Inc's 10-K filed December 22, 2025, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$79.9B
Institutions reporting
1,441
Shares held vs prior quarter
▲ 4.5%
Positions opened / closed
185 / 134

Top buyers and sellers, Q2 2026: 760 institutions bought and 629 sold ; the biggest buyer was Assenagon Asset Management S.A (+3.2M shares) and the biggest seller FMR LLC (−2.4M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $7.2B 16.2M 9.0% ▲ 2.1%
Vanguard Capital Management LLC $5.6B 12.5M 7.0% ▲ 0.5%
State Street Corp $4B 9.1M 5.1% ▲ 2.0%
Invesco Ltd. $2.7B 6.0M 3.4% ▲ 2.0%
FMR LLC $2.7B 6.0M 3.3% ▼ 28.4%
Assenagon Asset Management S.A. $2.2B 4.9M 2.7% ▲ 179.0%
Nvidia Corp $2.2B 4.8M 2.7% 0.0%
Geode Capital Management, LLC $2B 4.5M 2.5% ▼ 1.2%
Vanguard Portfolio Management LLC $2B 4.5M 2.5% ▼ 5.0%
Morgan Stanley $1.7B 3.8M 2.1% ▼ 3.8%
Van Eck Associates Corp $1.5B 3.5M 1.9% ▲ 19.7%
Aspex Management (HK) Ltd $1.4B 3.1M 1.7% ▲ 16.6%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Synopsys Inc's complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $61.5M 15 trades by 5 insiders · 89% under pre-set plans
Net ▼ $61.5M net selling
Insider Date Trade Shares Price Value
Ghazi Sassine PRESIDENT AND CEO October 15, 2026 Sell pre-set plan 14,604 $462.84 $6.8M
Kankanwadi Sudhindra Deputy CFO & CAO October 6, 2026 Sell 9,170 $500.00 $4.6M
Lee Janet GC & Corporate Secretary October 6, 2026 Sell 560 $502.39 $281,341
Lee Janet GC & Corporate Secretary October 6, 2026 Sell 584 $502.64 $293,344
Kankanwadi Sudhindra Deputy CFO & CAO October 5, 2026 Sell 3,000 $484.78 $1.5M
Ghazi Sassine PRESIDENT AND CEO September 15, 2026 Sell pre-set plan 14,604 $374.88 $5.5M
De Geus Aart EXECUTIVE CHAIR September 1, 2026 Sell pre-set plan 24,641 $419.44 $10.3M
De Geus Aart EXECUTIVE CHAIR August 31, 2026 Sell pre-set plan 25,000 $441.76 $11M
De Geus Aart EXECUTIVE CHAIR August 28, 2026 Sell pre-set plan 25,000 $445.55 $11.1M
Ghazi Sassine PRESIDENT AND CEO June 15, 2026 Sell pre-set plan 14,603 $458.96 $6.7M
Glaser Shelagh CFO June 12, 2026 Sell pre-set plan 3,394 $450.02 $1.5M
Lee Janet GC & Corporate Secretary January 12, 2026 Sell pre-set plan 250 $530.00 $132,500

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 26 trades and filings

In the last 12 months, 2 members of Congress disclosed 1 purchase and 1 sale of Synopsys Inc shares.

  • Dan Newhouse(R-WA 4):Purchase, $1,001 - $15,000, traded December 31, 2025, filed January 15, 2026
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (partial), $1,001 - $15,000, traded November 18, 2025, filed December 15, 2025
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (partial), $1,001 - $15,000, traded October 9, 2025, filed November 18, 2025

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 25, 2026 estimated from the company's past filing pattern, not announced

  • August 26, 2026
  • May 27, 2026
  • February 25, 2026
  • December 10, 2025
  • September 9, 2025
  • May 28, 2025

Recent SEC filings

Data status

When each part of this page on Synopsys Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Synopsys Inc in brief

What does Synopsys Inc do?
Synopsys Inc is a US-listed company in the application software industry. Its financial year ends in October.
What is Synopsys Inc's stock ticker?
Synopsys Inc trades under the ticker SNPS on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Synopsys Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Synopsys Inc reported revenue of $9.4B, 46.3% higher than a year earlier, according to its SEC filings.
What is Synopsys Inc's free cash flow?
Synopsys Inc's free-cash-flow margin is 29.2% of revenue over the trailing twelve months, ranking 30 of the 180 application software companies we cover.
Who are Synopsys Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and State Street Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Synopsys Inc's market cap?
On November 2, 2026, Synopsys Inc's market capitalisation was about $89B, with a price-to-earnings ratio of 82.7 and net debt of $6.5B. Market figures come from third-party market data and may be delayed.
How much debt does Synopsys Inc have?
Synopsys Inc's debt-to-equity ratio is 32.2%, from its latest balance sheet (0.5% five years earlier). The financial health section below sets out its other solvency checks.
Who are Synopsys Inc's competitors?
In our Application Software peer group, the companies closest to Synopsys Inc are Workday, Inc., Autodesk, Inc., Palantir Technologies Inc., Toast, Inc. and Atlassian Corp. The side-by-side comparison below sets their revenue, margins and growth against Synopsys Inc's.
Are insiders buying or selling Synopsys Inc stock?
Over the last 12 months, Synopsys Inc's directors and officers reported 0 open-market purchases and 15 sales on Form 4. The insider trading page charts every trade.
When is Synopsys Inc's next earnings date?
Around December 9, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Synopsys Inc announces its own schedule.